Results 171 to 180 of about 262,476 (307)

Effect of Social Media Advertisements on Adolescents' Sugar‐Sweetened Beverage Choices: A Randomized Field Experiment

open access: yesObesity, EarlyView.
ABSTRACT Objective This study aimed to quantify the impact of adolescents' exposure to unhealthy food marketing in real‐world digital environments. Methods We conducted a single‐blinded randomized field experiment including 121 Australian adolescents aged 16–17.
Max Treu   +4 more
wiley   +1 more source

G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models

open access: yesObesity, EarlyView.
This study identifies G protein‐coupled receptor 17 (Gpr17) as a novel regulator of leptin and insulin sensitivity. Using complementary knockout models, we demonstrate that Gpr17 deletion enhances energy expenditure, restores leptin responsiveness, and improves insulin sensitivity, revealing Gpr17 as a potential therapeutic GPCR target for obesity and ...
Xun Sun   +8 more
wiley   +1 more source

Response to “Stopping Spin at the Source: Learning From an Example in Obesity”

open access: yes
Obesity, EarlyView.
Huasheng Xiang   +5 more
wiley   +1 more source

Parental Communication With Children Around Obesity Management Medications, Weight Loss, and Health Behavior Change

open access: yesObesity, EarlyView.
ABSTRACT Objective This study aimed to describe parental communication with children around obesity management medications (OMMs) and child, parent, and family factors associated with communication. Methods Parents (N = 211; 80% mothers; 89% White) prescribed OMMs at a medical center participated in a survey about communication with children about OMM ...
Keeley J. Pratt   +3 more
wiley   +1 more source

Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial. [PDF]

open access: yesDiabetes Care
Bergenstal RM   +15 more
europepmc   +1 more source

Health Care Costs and Use of Patients Prescribed Four Different Obesity Medications

open access: yesObesity, EarlyView.
ABSTRACT Objective This study compared changes in health care costs and use across cohorts initiating four obesity medications (OMs). Methods Commercial insurance claims were used to identify new initiators of phentermine (n = 136,788), phentermine‐topiramate‐ER (n = 13,888), naltrexone‐bupropion‐SR (n = 28,712), or liraglutide (n = 49,266) for obesity.
Kristina H. Lewis   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy